1	Constitutive	constitutive	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	primary	primary	_	_	_	_	_	_	_
7	adult	adult	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	leukemia	leukemia	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	T-cell	T-cell	_	_	_	_	_	_	_
3	leukemia	leukemia	_	_	_	_	_	_	_
4	virus	virus	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	I	i	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	HTLV-I	HTLV-I	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	etiologic	etiologic	_	_	_	_	_	_	_
13	agent	agent	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	adult	adult	_	_	_	_	_	_	_
16	T-cell	t-cell	_	_	_	_	_	_	_
17	leukemia	leukemia	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	ATL	ATL	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	viral	viral	_	_	_	_	_	_	_
3	protein	protein	_	_	_	_	_	_	_
4	Tax	Tax	_	_	_	_	_	_	_
5	induces	induce	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	translocalization	translocalization	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	transcription	transcription	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	which	which	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	proposed	propose	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	play	play	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	crucial	crucial	_	_	_	_	_	_	_
23	role	role	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	transformation	transformation	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	T	t	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	HTLV-I	HTLV-I	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	HTLV-I	HTLV-I	_	_	_	_	_	_	_
5	genes	gene	_	_	_	_	_	_	_
6	including	include	_	_	_	_	_	_	_
7	Tax	Tax	_	_	_	_	_	_	_
8	are	be	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	expressed	express	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	primary	primary	_	_	_	_	_	_	_
14	leukemic	leukemic	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	ATL	atl	_	_	_	_	_	_	_
18	patients	patient	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	examined	examine	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	basis	basis	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	freshly	freshly	_	_	_	_	_	_	_
14	isolated	isolate	_	_	_	_	_	_	_
15	leukemic	leukemic	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	ATL	atl	_	_	_	_	_	_	_
19	patients	patient	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	leukemic	leukemic	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	ATL	atl	_	_	_	_	_	_	_
8	patients	patient	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	like	like	_	_	_	_	_	_	_
11	HTLV-I-infected	htlv-i-infected	_	_	_	_	_	_	_
12	T-cell	t-cell	_	_	_	_	_	_	_
13	lines	line	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	display	display	_	_	_	_	_	_	_
16	constitutive	constitutive	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	DNA	DNA	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	increased	increase	_	_	_	_	_	_	_
23	degradation	degradation	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	an	an	_	_	_	_	_	_	_
28	inhibitor	inhibitor	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Whereas	whereas	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
4	binding	binding	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	Tax-expressing	tax-expressing	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	lines	line	_	_	_	_	_	_	_
10	consisted	consist	_	_	_	_	_	_	_
11	mostly	mostly	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	p50/c-Rel	p50/c-rel	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	fresh	fresh	_	_	_	_	_	_	_
16	ATL	ATL	_	_	_	_	_	_	_
17	samples	sample	_	_	_	_	_	_	_
18	contained	contain	_	_	_	_	_	_	_
19	p50/p50	p50/p50	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	p50/p65	p50/p65	_	_	_	_	_	_	_
22	heterodimers	heterodimer	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	T-cell	t-cell	_	_	_	_	_	_	_
3	line	line	_	_	_	_	_	_	_
4	derived	derive	_	_	_	_	_	_	_
5	from	from	_	_	_	_	_	_	_
6	ATL	ATL	_	_	_	_	_	_	_
7	leukemic	leukemic	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	TL-Om1	TL-Om1	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	displayed	display	_	_	_	_	_	_	_
13	constitutive	constitutive	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	as	as	_	_	_	_	_	_	_
18	well	well	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	enhanced	enhance	_	_	_	_	_	_	_
21	degradation	degradation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	despite	despite	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	lack	lack	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	detectable	detectable	_	_	_	_	_	_	_
30	Tax	Tax	_	_	_	_	_	_	_
31	expression	expression	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	TL-Om1	TL-Om1	_	_	_	_	_	_	_
7	consists	consist	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	p50/p50	p50/p50	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	p50/p65	p50/p65	_	_	_	_	_	_	_
12	like	like	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	fresh	fresh	_	_	_	_	_	_	_
16	primary	primary	_	_	_	_	_	_	_
17	leukemic	leukemic	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	occurs	occur	_	_	_	_	_	_	_
9	through	through	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	Tax-independent	tax-independent	_	_	_	_	_	_	_
12	mechanism	mechanism	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	leukemic	leukemic	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	ATL	atl	_	_	_	_	_	_	_
18	patients	patient	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	possibly	possibly	_	_	_	_	_	_	_
21	due	due	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	differential	differential	_	_	_	_	_	_	_
24	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
25	subunit	subunit	_	_	_	_	_	_	_
26	activation	activation	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

